Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Lin-Lin Lee, An-Ping Huo & Shu-Ling Chen. (2023) Experiences and coping behaviors of patients with psoriasis: a qualitative study. Journal of Dermatological Treatment 34:1.
Read now
Read now
James Cheng-Chung Wei, Yi-Jung Chang, Yu-Hsun Wang & Chih-Jung Yeh. (2022) The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan. Clinical Epidemiology 14, pages 265-273.
Read now
Read now
James Cheng-Chung Wei, Yi-Jung Chang, Yu-Hsun Wang & Chih-Jung Yeh. (2022) The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan. Clinical Epidemiology 14, pages 265-273.
Read now
Read now
Andrew Blauvelt, Kenneth B. Gordon, Patricia Lee, Jerry Bagel, Howard Sofen, Benjamin Lockshin, Ahmed M. Soliman, Ziqian Geng, Tianyu Zhan, Gabriela Alperovich & Linda Stein Gold. (2022) Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. Journal of Dermatological Treatment 33:4, pages 2085-2093.
Read now
Read now
Sascha Gerdes, Manuel Velasco, Jashin J. Wu, Mario Hubo & Karen A. Veverka. (2021) Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE). Journal of Dermatological Treatment 32:8, pages 883-893.
Read now
Read now
Christian Termeer, Uwe Reinhold, Thomas Dirschka, Ralph von Kiedrowski & Hjalmar Kurzen. (2021) Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice. Journal of Dermatological Treatment 32:6, pages 610-616.
Read now
Read now
Jashin J. Wu, Karen A. Veverka, Minyi Lu & April W. Armstrong. (2019) Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States. Journal of Dermatological Treatment 30:5, pages 454-460.
Read now
Read now
Inge M. G. J. Bronckers, Maartje J. van Geel, Peter C. M. van de Kerkhof, Elke M. G. J. de Jong & Marieke M. B. Seyger. (2019) A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity. Journal of Dermatological Treatment 30:3, pages 208-215.
Read now
Read now
Rui Lai, Dehai Xian, Xia Xiong, Lingyu Yang, Jing Song & Jianqiao Zhong. (2018) Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Report 23:1, pages 130-135.
Read now
Read now
Michael Roman & Melvin W Chiu. (2017) Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy. Drug Design, Development and Therapy 11, pages 2065-2075.
Read now
Read now
Boni E. Elewski, Lluís Puig, Margaret Mordin, Isabelle Gilloteau, Bintu Sherif, Todd Fox, Ari Gnanasakthy, Charis Papavassilis & Bruce E. Strober. (2017) Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75–89 response: results from two phase 3 studies of secukinumab. Journal of Dermatological Treatment 28:6, pages 492-499.
Read now
Read now
Claus Bang Pedersen, Colleen A. McHorney, Lotte Seiding Larsen, Katja Wendicke Lophaven, Anders Holmen Moeller & Matthew Reaney. (2017) Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris. Journal of Dermatological Treatment 28:3, pages 213-220.
Read now
Read now
Marjolein I. A. Koetsier & Peter C. M. van de Kerkhof. (2015) “Patient-centered treatment” for mild-to-moderate psoriasis. Journal of Dermatological Treatment 26:1, pages 1-6.
Read now
Read now
Articles from other publishers (61)
D. Rogner, L. Heimerl, S. Heyer, T. Biedermann, E. Sattler & A. Zink. (2023)
Patients' perspective, quality of life and treatment goals in
Hailey–Hailey
disease: Lessons learned from the German National Registry
. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Bruce Strober, Carle Paul, Andrew Blauvelt, Diamant Thaçi, Luis Puig, Mark Lebwohl, Katy White, Veerle Vanvoorden, Delphine Deherder, Natalie Nunez Gomez & Kilian Eyerich. (2023) Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial. Journal of the American Academy of Dermatology 89:3, pages 486-495.
Crossref
Crossref
Gloria‐Beatrice Wintermann, Antonie Louise Bierling, Eva M. J. Peters, Susanne Abraham, Stefan Beissert & Kerstin Weidner. (2023) Psychosocial stress affects the change of mental distress under dermatological treatment—A prospective cohort study in patients with psoriasis. Stress and Health.
Crossref
Crossref
Anne Crochard, Alexandre Gherardi, Mélanie Hueber Kollen, Seham Issa & Axel Villani. (2023) Assessing the burden of patients with psoriasis through the concept of cumulative life course impairment: A narrative literature review. JEADV Clinical Practice.
Crossref
Crossref
Farshid Saeedinezhad, Hanie Dahmardeh, Fariba Yaghoubinia & Jamshid Hossein Zehi Zamani. (2023) Exploring the Experiences of Patients with Psoriasis: A Phenomenological Study. Medical-Surgical Nursing Journal 11:3.
Crossref
Crossref
Antonia-Luise Newi, Athanasios Tsianakas, Sophia von Martial, Rachel Sommer & Christine Blome. (2022) How important is subjective well-being for patients? A qualitative interview study of people with psoriasis. Quality of Life Research 31:12, pages 3355-3363.
Crossref
Crossref
Petra Staubach, Katrin Veelen, Sebastian Zimmer, Anna Sohn, Berenice M. Lang, Adriane Peveling-Oberhag, Stephan Grabbe, Wiebke Kaluza-Schilling, Andreas Schwarting & Joanna Wegner. (2022) Multidisziplinarität als Schlüssel zum ErfolgMultidisciplinarity as the key to success. Die Dermatologie 73:11, pages 866-871.
Crossref
Crossref
Kamila Jaworecka, Marian Rzepko, Luiza Marek-Józefowicz, Funda Tamer, Aleksandra A. Stefaniak, Magdalena Szczegielniak, Joanna Chojnacka-Purpurowicz, Ayla Gulekon, Jacek C. Szepietowski, Joanna Narbutt, Agnieszka Owczarczyk-Saczonek & Adam Reich. (2022) The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis. Journal of Clinical Medicine 11:19, pages 5553.
Crossref
Crossref
Pablo Chicharro, Mar Llamas‐Velasco, Susana Armesto, Enrique Herrera‐Acosta, David Vidal, Eva Vilarrasa, Raquel Rivera, Pablo De la Cueva, Antonio Martorell‐Calatayud, Ferrán Ballescà, Isabel Belinchón, Gregorio Carretero, Lourdes Rodríguez, Alberto Romero‐Maté, Josep Pujol‐Montcusí, Laura Salgado, Antonio Sahuquillo‐Torralba, Pablo Coto‐Segura, Ofelia Baniandrés‐Rodríguez, Rosa Feltes, Mercè Alsina & Esteban Daudén. (2022) Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting. Dermatologic Therapy 35:8.
Crossref
Crossref
Carolina Mesa, María Paulina Estrada, Elsa María Vásquez-Trespalacios, Alejandra Jaramillo, Daniela Morales, Juliana Madrigal-Cadavid, Paulo Andrés Giraldo, Jorge Iván Estrada-Acevedo & Ángela Londoño. (2022) Caracterización clínica, sociodemográfica, farmacológica y calidad de vida de pacientes con diagnóstico de psoriasis moderada a severa atendidos en una clínica especializada en psoriasis. CES Medicina 36:1, pages 17-29.
Crossref
Crossref
Gloria-Beatrice Wintermann, Antonie Louise Bierling, Eva M. J. Peters, Susanne Abraham, Stefan Beissert & Kerstin Weidner. (2022) Childhood Trauma and Psychosocial Stress Affect Treatment Outcome in Patients With Psoriasis Starting a New Treatment Episode. Frontiers in Psychiatry 13.
Crossref
Crossref
Shushanik Karapetyan, Hayk Davtyan, Khachik Khachikyan & Gagik Hakobyan. (2022) Impact of supplemental essential phospholipids on treatment outcome and quality of life of patients with psoriasis with moderate severity. Dermatologic Therapy 35:4.
Crossref
Crossref
Rossella Mattea Quinto, Francesco De Vincenzo, Dario Graceffa, Claudio Bonifati, Marco Innamorati & Luca Iani. (2022) The Relationship between Alexithymia and Mental Health Is Fully Mediated by Anxiety and Depression in Patients with Psoriasis. International Journal of Environmental Research and Public Health 19:6, pages 3649.
Crossref
Crossref
Vishal Thakur & Rahul Mahajan. (2022) Novel Therapeutic Target(s) for Psoriatic Disease. Frontiers in Medicine 9.
Crossref
Crossref
A. A. Hotko & N. S. Rudneva. (2021) Cardiovascular risks in patients with psoriasis (literature review). Medical alphabet:34, pages 12-17.
Crossref
Crossref
Nuria Gago‐López, Carmen Lagunas Arnal, Juan J. Perez & Erwin F. Wagner. (2021) Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model. Experimental Dermatology 30:11, pages 1662-1674.
Crossref
Crossref
Alice B. Gottlieb, Richard B. Warren, Matthias Augustin, Llenalia Garcia, Christopher Cioffi, Luke Peterson, Christopher Pelligra & Valerie Ciaravino. (2021) Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial. Advances in Therapy 38:10, pages 5253-5269.
Crossref
Crossref
Karina Wierzbowska-Drabik, Aleksandra Lesiak, Małgorzata Skibińska, Michał Niedźwiedź, Jarosław D. Kasprzak & Joanna Narbutt. (2021) Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics. International Journal of Molecular Sciences 22:19, pages 10402.
Crossref
Crossref
Chang Zeng, Lam C. Tsoi & Johann E. Gudjonsson. (2021) Dysregulated epigenetic modifications in psoriasis. Experimental Dermatology 30:8, pages 1156-1166.
Crossref
Crossref
Jo Lambert, Jes Birger Hansen, Anne Sohrt & Luis Puig. (2021) Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab. Dermatology and Therapy 11:4, pages 1265-1275.
Crossref
Crossref
Richard B. Warren, Alice B. Gottlieb, Joseph F. Merola, Llenalia Garcia, Christopher Cioffi, Luke Peterson, Christopher Pelligra & Valerie Ciaravino. (2021) Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials. Dermatology and Therapy.
Crossref
Crossref
Francesca CAROPPO, Matteo ZACCHINO, Eleonora MILAZZO, Elena FONTANA, Francesca NOBILE, Cristina MAROGNA, Laura VENTURA & Anna BELLONI FORTINA. (2021) Quality of life in children with psoriasis: results from a monocentric study. Italian Journal of Dermatology and Venereology 156:3.
Crossref
Crossref
Mohammad Javad Yazdanpanah, Sadegh Vahabi-Amlashi, Marzieh Pishgouy, Mohammad Imani, Mahnaz Banihashemi, Amir Hooshang Mohammadpoor, Mohammad Khajedaluee, Hamidreza Bahrami-Taghanaki & Hoda Azizi. (2021) Comparing the topical preparations of Indigo naturalis from Chinese and Iranian origin in the treatment of plaque-type psoriasis: A preliminary randomized double-blind pilot study. European Journal of Integrative Medicine 43, pages 101310.
Crossref
Crossref
Emmanuel Mahe, Sarah‐Hind Moumane & Murielle Foist. (2021) Topical medications for chronic plaque psoriasis: A 3‐year longitudinal study in France. Dermatologic Therapy 34:2.
Crossref
Crossref
M. Augustin, E. Dauden, U. Mrowietz, M.P. Konstantinou, S. Gerdes, K. Kingo, J.C. Szepietowski, J.L. Perrot, A. Cuccia, M. Rissler, S. Gathmann, C. Sieder, R. Orsenigo, P. Jagiello & T. Bachhuber. (2020) Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology 35:2, pages 431-440.
Crossref
Crossref
Yulia V. AGAFONOVA & Daria L. SIMONOVA. (2021) Stigmatization and social ostracism of patients with psoriasis: a qualitative phenomenological study. Medicine and Physical Education: Science and Practice:11, pages 42-50.
Crossref
Crossref
Alan Maddock, David Hevey, Paul D’Alton & Brian Kirby. (2019) Examining Individual Differences in Wellbeing, Anxiety and Depression in Psoriasis Using a Clinically Modified Buddhist Psychological Model. Journal of Clinical Psychology in Medical Settings 27:4, pages 842-858.
Crossref
Crossref
M. Augustin, E. Dauden, U. Mrowietz, M.P. Konstantinou, S. Gerdes, M. Rissler, S. Gathmann, C. Sieder, D. Baeumer & R. Orsenigo. (2020) Baseline characteristics of patients with moderate‐to‐severe psoriasis according to previous systemic treatment exposure: the PROSE study population. Journal of the European Academy of Dermatology and Venereology 34:11, pages 2548-2556.
Crossref
Crossref
Luca Iani, Rossella Mattea Quinto, Piero Porcelli, Andrea-René Angeramo, Andrea Schiralli & Damiano Abeni. (2020) Positive Psychological Factors Are Associated With Better Spiritual Well-Being and Lower Distress in Individuals With Skin Diseases. Frontiers in Psychology 11.
Crossref
Crossref
B. Halioua, F. Maccari, A.‐C. Fougerousse, J. Parier, Z. Reguiai, C. Taieb & E. Esteve. (2020) Impact of patient psoriasis on partner quality of life, sexuality and empathy feelings: a study in 183 couples. Journal of the European Academy of Dermatology and Venereology 34:9, pages 2044-2050.
Crossref
Crossref
K. Reich, R.B. Warren, L.C. Coates & G. Di Comite. (2020) Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease. Journal of the European Academy of Dermatology and Venereology 34:6, pages 1161-1173.
Crossref
Crossref
Lihua Gao, Jianhua Dou, Bo Zhang, Jinrong Zeng, Qingmei Cheng, Li Lei, Lina Tan, Qinghai Zeng, Shu Ding, Aiyuan Guo, Haipeng Cheng, Caifeng Yang, Ziqiang Luo & Jianyun Lu. (2020) Ozone therapy promotes the differentiation of basal keratinocytes via increasing Tp63‐mediated transcription of KRT10 to improve psoriasis. Journal of Cellular and Molecular Medicine 24:8, pages 4819-4829.
Crossref
Crossref
Fariba Yaghoubinia, Farshid Saeedinezhad, Asadollah Keikhaei & Fatemeh Piri. (2020) Experiences of Young Girls with Psoriasis: A Descriptive Phenomenological Study. Medical - Surgical Nursing Journal 8:4.
Crossref
Crossref
María Laura Galimberti, Aldana S. Vacas, Barbara A. Hernández, María L. Bollea Garlatti, María J. Cura & Ricardo L. Galimberti. (2020) Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina. Anais Brasileiros de Dermatologia 95:1, pages 20-24.
Crossref
Crossref
Finola M. Bruins, Inge M. G. J. Bronckers, Hans M. M. Groenewoud, Peter C. M. van de Kerkhof, Elke M. G. J. de Jong & Marieke M. B. Seyger. (2020) Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients. JAMA Dermatology 156:1, pages 72.
Crossref
Crossref
Francesca Sampogna, Simona Mastroeni, Sabatino Pallotta, Roberta Fusari, Claudia Uras, Monica Napolitano & Damiano Abeni. (2019) Use of the SF‐12 questionnaire to assess physical and mental health status in patients with psoriasis. The Journal of Dermatology 46:12, pages 1153-1159.
Crossref
Crossref
Olivia Charlton, Kevin Phan, Saxon D Smith & John Parratt. (2019) Psoriasis in family members of patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 36, pages 101421.
Crossref
Crossref
B. Tamási, V. Brodszky, M. Péntek, L. Gulácsi, K. Hajdu, M. Sárdy, A. Szegedi, Z. Bata‐Csörgő, Á. Kinyó & F. Rencz. (2018)
Validity of the
EQ
‐5D in patients with pemphigus vulgaris and pemphigus foliaceus
. British Journal of Dermatology 180:4, pages 802-809.
Crossref
Crossref
Chia-Yu Liu, Tao-Hsin Tung, Chin-Yu Lee, Kuo-Hsuan Chang, Shu-Hui Wang & Ching-Chi Chi. (2018) Association of Multiple Sclerosis with Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies. American Journal of Clinical Dermatology 20:2, pages 201-208.
Crossref
Crossref
Uwe Wollina. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology
131
144
.
S.C.‐S. Hu, C.‐L. Lin & H.‐P. Tu. (2018) Association between psoriasis, psoriatic arthritis and gout: a nationwide population‐based study. Journal of the European Academy of Dermatology and Venereology 33:3, pages 560-567.
Crossref
Crossref
Kassab* YW. (2019) The impact of skin disorders on patients’ quality of life in Malaysia. Journal of Clinical Intensive Care and Medicine 4:1, pages 001-009.
Crossref
Crossref
D.E. Stull, C.E.M. GriffithsI. Gilloteau, Y. ZhaoA. GuanaA.Y. FinlayB. SherifK. HoughtonL. Puig. (2018) Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis. British Journal of Dermatology 178:6, pages 1297-1307.
Crossref
Crossref
D. Jungen, M. Augustin, A. Langenbruch, N. Zander, K. Reich, K. Strömer, D. Thaci, S. Purwins, M. Radtke & M. Gutknecht. (2017) Cost‐of‐illness of psoriasis – results of a German cross‐sectional study. Journal of the European Academy of Dermatology and Venereology 32:1, pages 174-180.
Crossref
Crossref
I V Kozlova, Yu N Myalina, L P Lipina & A L Bakulev. (2017) Optimization of therapy for hepatobiliary disorders in psoriatic patients. Terapevticheskii arkhiv 89:12-2, pages 204-210.
Crossref
Crossref
Stephen Hu & Cheng-Che E. Lan. (2017) Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. International Journal of Molecular Sciences 18:10, pages 2211.
Crossref
Crossref
Hojatolah Karimipour, Neda Sayadi, Abdolali Shariati, Mohammad Hossein Haghighi & Reza Yaghoubi. (2017) The Effects of a Self-Care Program on Promoting Self-Care Behaviors in Patients with Psoriasis. Jundishapur Journal of Chronic Disease Care 6:3.
Crossref
Crossref
Ming-Ann Hsu, James Lucas, Robert Wood, Joseph C. Cappelleri & James Piercy. (2017) Frequency, Prevalence, and Burden of Flares on Patients with Moderate to Severe Psoriasis: A Retrospective Cross-Sectional Analysis. Journal of Psoriasis and Psoriatic Arthritis 2:3, pages 64-70.
Crossref
Crossref
Sophie Glatt, Eric Helmer, Birgit Haier, Foteini Strimenopoulou, Graham Price, Pavan Vajjah, Olivier A. Harari, John Lambert & Stevan Shaw. (2017) First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis. British Journal of Clinical Pharmacology 83:5, pages 991-1001.
Crossref
Crossref
MM Hutmacher, K Papp, S Krishnaswami, K Ito, H Tan, R Wolk, H Valdez, C Mebus, ST Rottinghaus & P Gupta. (2017) Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight. CPT: Pharmacometrics & Systems Pharmacology 6:5, pages 322-330.
Crossref
Crossref
Bruce Strober, Alice B. Gottlieb, Bintu Sherif, Patrick Mollon, Isabelle Gilloteau, Lori McLeod, Todd Fox, Margaret Mordin, Ari Gnanasakthy, Charis Papavassilis & Mark G. Lebwohl. (2017) Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept. Journal of the American Academy of Dermatology 76:4, pages 655-661.
Crossref
Crossref
U. Mrowietz, J.C. Szepietowski, R. Loewe, P. van de Kerkhof, R. Lamarca, W.G. Ocker, V.M. Tebbs & I. Pau-Charles. (2017)
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm
®
- and placebo-controlled trial (BRIDGE)
. British Journal of Dermatology 176:3, pages 615-623.
Crossref
Crossref
April W. Armstrong, J. Will Koning, Simon Rowse, Huaming Tan, Carla Mamolo & Mandeep Kaur. (2016) Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data. Dermatology and Therapy 7:1, pages 97-109.
Crossref
Crossref
U. Mrowietz, A. Hartmann, W. Weißmann & I. Zschocke. (2017) FamilyPso - a new questionnaire to assess the impact of psoriasis on partners and family of patients. Journal of the European Academy of Dermatology and Venereology 31:1, pages 127-134.
Crossref
Crossref
P. de la Cueva Dobao. (2016) Psoriasis: aportación y valor de las asociaciones de pacientes. Actas Dermo-Sifiliográficas 107:9, pages 707-708.
Crossref
Crossref
M. Gutknecht, M.-L. Schaarschmidt, O. Herrlein & M. Augustin. (2016) A systematic review on methods used to evaluate patient preferences in psoriasis treatments. Journal of the European Academy of Dermatology and Venereology 30:9, pages 1454-1464.
Crossref
Crossref
Alireza Ghorbanibirgani, Masoud Fallahi-Khoshknab, Kourosh Zarea & Heidarali Abedi. (2016) The Meaning of Coping With Psoriasis: A Phenomenological Study. Jundishapur Journal of Chronic Disease Care 5:4.
Crossref
Crossref
Alireza Ghorbanibirgani, Masoud Fallahi-Khoshknab, Kourosh Zarea & Heidarali Abedi. (2016) The Lived Experience of Psoriasis Patients from Social Stigma and Rejection: A Qualitative Study. Iranian Red Crescent Medical Journal 18:7.
Crossref
Crossref
Jose Luis López‐Estebaranz, Jose Luis Sánchez‐Carazo & Sara Sulleiro. (2015)
Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: Results from the
ARIZONA
study
. The Journal of Dermatology 43:4, pages 395-401.
Crossref
Crossref
Yalçın BAŞ, Havva Yıldız SEÇKİN, Göknur KALKAN, Zennure TAKCI, Rıza ÇITIL, Yalçın ÖNDER, Şafak ŞAHİN & Ayşe Kevser DEMİR. (2016) Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 303-309.
Crossref
Crossref
Alexandra Price & David E. Cohen. (2014) Assessment of Pruritus in Patients With Psoriasis and Atopic Dermatitis. Dermatitis 25:6, pages 334-344.
Crossref
Crossref